As major miners retreat amid volatile markets, stablecoin giant Tether launches an ambitious software suite aimed at industrializing and streamlining Bitcoin mining operations worldwide.
President Trump signals openness for China and India to purchase Venezuelan crude, marking a potential shift in U.S. sanctions policy and global oil flows, with strategic implications for asphalt supply chains and geopolitical alliances.
Despite a challenging economic landscape marked by tariff pressures and soft MRO demand, W.W. Grainger reported resilient 2025 results, achieving 4.9% organic sales growth and strategic progress. The industrial supplies leader is doubling down on technology, supply chain expansion, and customer experience to drive market share gains in the coming year.
Marathon Petroleum Corporation (MPC) reported robust full-year 2025 financial performance, driven by strong refining margins and operational execution. The company highlighted a disciplined capital strategy, strategic midstream growth, and a positive outlook for refined product demand into 2026.
U.S. Attorney Jeanine Pirro faces intense backlash from Republican lawmakers and gun rights advocates after stating in a televised interview that anyone bringing a firearm into Washington, D.C. would face jail time, forcing a rare public rift among conservatives on gun policy.
As companies grapple with bloated software portfolios, a push for Go-To-Market platform consolidation is gaining momentum. Beyond cost savings, executives are finding that a unified system is critical for data integrity, sales velocity, and strategic agility in a competitive market.
Analysts at Clear Street have increased their price target for Wave Life Sciences to $50, maintaining a Buy rating. The move follows GSK's decision to return rights to the alpha-1 antitrypsin deficiency candidate WVE-006, which the firm views favorably despite a muted market reaction.
Amidst the glitter of gold medals lies a stark financial reality for many American Olympic athletes. With no state salary and often crippling costs, a historic private donation seeks to change the game.
Fubo CEO David Gandler downplays immediate changes from Josh D'Amaro's Disney appointment, focusing instead on executing the post-Hulu merger strategy and navigating content disputes.
As active ETF launches shattered records in 2025, financial advisors are weighing the structural shift alongside key macroeconomic indicators shaping portfolio strategies this week.
As Israel's conflicts stretch into a third year, a wave of defense technology startups—founded and staffed by reservists with direct combat experience—is attracting record investment and global demand, despite mounting international scrutiny over Gaza.
Despite a post-earnings selloff driven by surging capital expenditures, Microsoft's record $625 billion in future contracted revenue, heavily tied to AI demand, presents a compelling long-term case for investors.
The global private markets investment firm reported robust growth across assets under management and fee-related earnings, while detailing the closing of a major strategic partnership and continued momentum in its semi-liquid Evergreen funds.
YONEX (TSE:7906) shares have entered a consolidation phase after a stellar long-term run, with recent price weakness sparking debate among investors. While the stock trades at a premium based on earnings multiples, discounted cash flow models suggest potential undervaluation, creating a complex picture for the sporting goods giant.
Walt Disney names Josh D'Amaro, current chairman of Disney Experiences, as its next chief executive, succeeding Bob Iger. The move signals a strategic focus on the company's highly profitable parks and consumer products division.
Home Depot is undertaking a significant operational overhaul, eliminating approximately 800 corporate roles, mandating a full-time return to office, and internalizing its marketing strategy. The moves signal a push for greater efficiency and control as the home improvement giant navigates a fluctuating market.
Pfizer reported stronger-than-expected fourth-quarter earnings, defying analyst predictions even as revenue from its COVID-19 portfolio plummeted. The pharmaceutical giant's non-COVID products showed robust growth, signaling a strategic shift.
The benchmark diesel price, a key component in fuel surcharges, has risen for the third week in a row. However, a significant shift in futures contracts suggests the recent rally may be losing steam, even as analysts debate underlying structural strength in the market.
Shares of Illinois Tool Works have gained momentum, prompting investors to scrutinize whether its current price fully reflects the diversified manufacturer's earnings potential and growth prospects amid a mixed industrial landscape.
Backed by top-tier VCs, Lotus Health launches an AI-driven primary care service licensed across the U.S., promising free, 24/7 access while navigating complex healthcare regulations with human oversight.
